Ocular manifestations of lipid disorders: Clinical clues for lipidologists narrative review

Scritto il 14/11/2026
da Ron T Varghese

J Clin Lipidol. 2026 Nov 11:S1933-2874(26)00562-3. doi: 10.1016/j.jacl.2026.10.018. Online ahead of print.

ABSTRACT

BACKGROUND: Lipid disorders can produce recognizable findings in the eyelids, cornea, lens, and retina. Although many are nonspecific, selected phenotypes may signal severe hypercholesterolemia, chylomicronemia, or an inherited disorder of lipid metabolism.

SOURCES OF MATERIAL: PubMed was searched from inception through August 31, 2026, using terms related to dyslipidemia, inherited lipid disorders, and ocular phenotypes. English-language human studies, clinical guidance, randomized trials, systematic reviews, cohort studies, and phenotype-defining case series were prioritized. As this was a narrative review, formal preferred reporting items for systematic reviews and meta-analyses screening, duplicate selection, risk-of-bias assessment, and meta-analysis were not performed.

ABSTRACT OF FINDINGS: Clinically informative findings include xanthelasma, premature corneal arcus, lipemia retinalis, retinal hard exudates, diffuse corneal opacity with very low high-density lipoprotein cholesterol, juvenile cataracts, and pigmentary retinopathy with very low apolipoprotein B. Xanthelasma and corneal arcus may support evaluation but are not independent cardiovascular risk markers. Lipemia retinalis indicates severe chylomicronemia and should prompt assessment of pancreatitis risk. Less common phenotypes may suggest lecithin-cholesterol acyltransferase deficiency, Schnyder corneal dystrophy, cerebrotendinous xanthomatosis, or abetalipoproteinemia. Randomized trials indicate that fenofibrate can slow early diabetic retinal disease progression, although it does not replace established ophthalmic treatment.

CONCLUSION: Ocular examination can provide accessible evidence of systemic lipid disturbance. Clinical value lies in distinguishing common nonspecific findings from phenotypes suggesting severe hypertriglyceridemia, possible familial hypercholesterolemia, acute retinal vascular disease, or rare inherited lipid disorders.

PMID:43034116 | DOI:10.1016/j.jacl.2026.10.018